Current status of porous coordination networks (PCNs) derived porphyrin spacers for cancer therapy

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries.CA. CA A Cancer J Clinicians. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Ahmed S, Eng C. Role of chemotherapy in the neoadjuvant/adjuvant setting for patients with rectal adenocarcinoma undergoing chemoradiotherapy and surgery or radiotherapy and surgery. Curr Oncol Rep. 2018;20(1):1523–3790. doi: 10.1007/s11912-018-0652-7
   Web of Science ®Google Scholar
• Chen XY, Liu YY, Bu WB. Chemodynamic therapy: integration of Fenton chemistry and biomedicine. Scientia Sinica Chimica. 2020;50(2):159–172. doi: 10.1360/SSC-2019-0128
   Google Scholar
• Zhang J, Jiang C, Figueiró Longo JP, et al. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B. 2018;8(2):137–146. doi: 10.1016/j.apsb.2017.09.003
   PubMed Web of Science ®Google Scholar
• Deng X, Shao Z, Zhao Y. Solutions to the drawbacks of photothermal and photodynamic cancer therapy. Adv Sci. 2021;8(3):2002504. doi: 10.1002/advs.202002504
   Web of Science ®Google Scholar
• Ouyang J, Tang ZM, Farokhzad N, et al. Ultrasound mediated therapy: recent progress and challenges in nanoscience. Nano Today. 2020;35:100949. doi: 10.1016/j.nantod.2020.100949
   Web of Science ®Google Scholar
• Ma DY, Li Z, Zhu JX, et al. Inverse and highly selective separation of CO2/C2H2 on a thulium–organic framework. J Mater Chem A. 2020;8:11933–11937. doi: 10.1039/D0TA03151H
   Web of Science ®Google Scholar
• Yang J, Yang YW. Metal–organic frameworks for biomedical applications. Small. 2020; 16(10):1906846. doi: 10.1002/smll.201906846
   PubMed Web of Science ®Google Scholar
• Mandal S, Natarajan S, Mani P, et al. Post‐Synthetic modification of metal–organic frameworks toward applications. Adv Funct Mater. 2021;31(4):2006921. doi: 10.1002/adfm.202006291
   Web of Science ®Google Scholar
• Guo XR, Zhou LY, Liu XZ, et al. Fluorescence detection platform of metal-organic frameworks for biomarkers, colloid. Surface B. 2023;229:113455. doi: 10.1016/j.colsurfb.2023.113455
   PubMed Web of Science ®Google Scholar
• Wang D, Sun E. Loading carboxyfluorescein into porous SiO2 spheres and UCNPs- cored porous SiO2 spheres: emission turn-on sensing with a warning signal for tumor-biomarker 5-HIAA urine test. Micropor Mesopor Mat. 2020;299:110131. doi: 10.1016/j.micromeso.2020.110131
   Web of Science ®Google Scholar
• Obayemi JD, Jusu SM, Salifu AA, et al. Degradable porous drug-loaded polymer scaffolds for localized cancer drug delivery and breast cell/tissue growth. Mater Sci Eng: C. 2020;112:110794. doi: 10.1016/j.msec.2020.110794
   PubMed Web of Science ®Google Scholar
• Zhong YY, Peng ZX, Peng YQ, et al. Construction of Fe-doped ZIF-8/DOX nanocomposites for ferroptosis strategy on the treatment of breast cancer. J Mater Chem B. 2023;11:6335–6345. doi: 10.1039/D3TB00749A
   PubMed Web of Science ®Google Scholar
• Chen XL, Li MM, Lin MZ, et al. Current and promising applications of Hf(IV)-based MOFs in clinical cancer therapy. J Mater Chem B. 2023;11:5693–5714. doi: 10.1039/D3TB00267E
   PubMed Web of Science ®Google Scholar
• Ma SQ, Sun DF, Simmons JM, et al. Metal-organic framework from an anthracene derivative containing nanoscopic cages exhibiting high methane uptake. J Am Chem Soc. 2008;130(3):1012–1016. doi: 10.1021/ja0771639
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhan G, Zhang Z, et al. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors. Theranostics. 2021;11(4):1937–1952. doi: 10.7150/thno.45511
   PubMed Web of Science ®Google Scholar
• Chen JJ, Zhu YF, Kaskel S. Porphyrin-based metal-organic frameworks for biomedical applications. Angew Chem Int Ed Engl. 2021; 60(10):5010–5035. doi: 10.1002/anie.201909880
   PubMed Web of Science ®Google Scholar
• Tang ZM, Liu YY, He MY, et al. Chemodynamic therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like reactions. Angew Chem Int Ed Engl. 2019;58(4):946–956. doi: 10.1002/anie.201805664
   PubMed Web of Science ®Google Scholar
• Mizushima E, Tsukahara T, Emori M, et al. Osteosarcoma‐initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B. Cancer Sci. 2020;111(1):36–46. doi: 10.1111/cas.14229
   PubMed Web of Science ®Google Scholar
• Chen Q, Liang C, Sun X, et al. H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay [biochemistry]. Proc Natl Acad Sci USA. 2017;114(21):5343–5348. doi: 10.1073/pnas.1701976114
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Tamada A, Kumai H, et al. Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer. 2002;99(3):474–479. doi: 10.1002/ijc.10387
   PubMed Web of Science ®Google Scholar
• Montes P, Bernal M, Campo LN, et al. Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression. Cancer Immunol Immunother. 2019;68(12):2015–2027. doi: 10.1007/s00262-019-02420-x
   PubMed Web of Science ®Google Scholar
• Yang E, Wang X, Gong Z, et al. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Sig Transduct Target Ther. 2020;5(1):13. doi: 10.1038/s41392-020-00359-5
   PubMed Web of Science ®Google Scholar
• Shi YH, Du J, Pan W, et al. Crosstalk between the tumor microenvironment and tumor cells through exosomes: Roles in tumor metabolism and progression. J Nutr Oncol. 2023;8(1):9.
   Google Scholar
• Wang Z, Liu B, Sun QQ, et al. Fusiform-like Copper(II)-based metal-organic framework through relief hypoxia and GSH-Depletion co-enhanced starvation and chemodynamic synergetic cancer therapy. ACS Appl Mater Interfaces. 2020;12(15):17254–17267. doi: 10.1021/acsami.0c01539
   PubMed Web of Science ®Google Scholar
• Zhan G, Xu Q, Zhang Z, et al. Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates anti-PD-1 therapy in hypoxic tumors. Nano Today. 2021;38:101195. doi: 10.1016/j.nantod.2021.101195
   Web of Science ®Google Scholar
• Liang S, Deng XR, Chang Y, et al. Intelligent hollow Pt-CuS janus architecture for synergistic catalysis-enhanced sonodynamic and photothermal cancer therapy. Nano Lett. 2019;19(6):4134–4145. doi: 10.1021/acs.nanolett.9b01595
   PubMed Web of Science ®Google Scholar
• Wang XS, Zeng JY, Zhang MK, et al. A versatile Pt-based core–shell nanoplatform as a nanofactory for enhanced tumor therapy. Adv Funct Mater. 2018;28(36):1801783. doi: 10.1002/adfm.201801783
   Web of Science ®Google Scholar
• Gao ZG, Li YJ, Zhang Y, et al. Biomimetic platinum nanozyme immobilized on 2D metal–organic frameworks for mitochondrion-targeting and oxygen self-supply photodynamic therapy. ACS Appl Mater Interfaces. 2020;12(2):1963–1972. doi: 10.1021/acsami.9b14958
   PubMed Web of Science ®Google Scholar
• Bao YH, Chen JF, Qiu HQ, et al. Erythrocyte membrane-camouflaged PCN-224 nanocarriers integrated with platinum nanoparticles and glucose oxidase for enhanced tumor sonodynamic therapy and synergistic starvation therapy. ACS Appl Mater Interfaces. 2021;13(21):24532–24542. doi: 10.1021/acsami.1c05644
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu WJ, Yang Z, et al. Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy. Theranostics. 2023;13(5):1571–1583. doi: 10.7150/thno.79945
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14(6):430–439. doi: 10.1038/nrc3726
   PubMed Web of Science ®Google Scholar
• Ren Q, Yu N, Wang LY, et al. Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy. J Colloid Interface Sci. 2022;614(15):147–159. doi: 10.1016/j.jcis.2022.01.050
   PubMedGoogle Scholar
• Hoang QT, Kim M, Kim BC, et al. Pro-oxidant drug-loaded porphyrinic zirconium metal-organic-frameworks for cancer-specific sonodynamic therapy. Colloids Surf B Biointerfaces. 2022;209:112189. doi: 10.1016/j.colsurfb.2021.112189
   PubMed Web of Science ®Google Scholar
• Shi JJ, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–665. doi: 10.1038/nature15514
   PubMed Web of Science ®Google Scholar
• Rao ZP, Zhu YT, Yang P, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12(9):4310–4329. doi: 10.7150/thno.71086
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Skarlatos J, et al. Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 2001;61(5):1830–1832.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Huang H. Breakthrough in construction of oxygen-independent photosensitizer for type III photodynamic therapy. Sci China Chem. 2022;65(005):834–835. doi: 10.1007/s11426-022-1218-0
   Google Scholar
• Li SY, Cheng H, Qiu WX, et al. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials. 2017;142:149–161. doi: 10.1016/j.biomaterials.2017.07.026
   PubMed Web of Science ®Google Scholar
• Li SY, Cheng H, Xie BR, et al. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy. ACS Nano. 2017;11(7):7006–7018. doi: 10.1021/acsnano.7b02533
   PubMed Web of Science ®Google Scholar
• Zhao J, Yang Y, Han X, et al. Redox-sensitive nanoscale coordination polymers for drug delivery and cancer theranostics. ACS Appl Mater & Interf. 2017;9(28):23555–23563.
   PubMed Web of Science ®Google Scholar
• Xie BX, Shu W, Wang HS, et al. Folic acid-modified metal-organic framework carries CPT and DOX for cancer treatment. J Solid State Chem. 2022;306:122803. doi: 10.1016/j.jssc.2021.122803
   Web of Science ®Google Scholar
• He M, Chen YN, Tao C, et al. Mn-porphyrin-based metal-organic framework with high longitudinal relaxivity for magnetic resonance imaging guidance and oxygen self-supplementing photodynamic therapy. ACS Appl Mater Interfaces. 2019;11(45):41946–41956. doi: 10.1021/acsami.9b15083
   PubMed Web of Science ®Google Scholar
• Sakamaki Y, Ozdemir J, Perez AD, et al. Maltotriose conjugated metal-organic frameworks for selective targeting and photodynamic therapy of triple negative breast cancer cells and tumor associated macrophages. Adv Ther. 2020;3:2000029. doi: 10.1002/adtp.202000029
   Google Scholar
• Vangara A, Pramanik A, Gao Y, et al. FRET based highly efficient theranostic nanoplatform for two-photon bio-imaging and two-photon excited photodynamic therapy of MDRB. ACS Appl Bio Mater. 2018;1(2):289–309. doi: 10.1021/acsabm.8b00071
   PubMedGoogle Scholar
• Chen NT, Tang KC, Chung MF, et al. Enhanced plasmonic resonance energy transfer in mesoporous silica-encased gold nanorod for two-photon-activated photodynamic therapy. Theranostics. 2014;4(8):798–807. doi: 10.7150/thno.8934
   PubMed Web of Science ®Google Scholar
• Chen JY, Zhang ZX, Ma JX, et al. Current status and prospects of MOFs as controlled delivery of Pt anticancer drugs. Dalton Trans. 2023;52:6226–6238. doi: 10.1039/D3DT00413A
   PubMed Web of Science ®Google Scholar
• Liu H, Yang Y, Wang A, et al. Hyperbranched polyglycerol-doped mesoporous silica nanoparticles for one- and two-photon activated photodynamic therapy. Adv Funct Mater. 2016;26:2561–2570. doi: 10.1002/adfm.201504939 15
   Web of Science ®Google Scholar
• Li B, Cao HZ, Zheng J, et al. Click modification of a metal-organic framework for two-photon photodynamic therapy with near-infrared excitation. ACS Appl Mater Interfaces. 2021;13(8):9739–9747. doi: 10.1021/acsami.1c00583
   PubMed Web of Science ®Google Scholar
• Li YT, Zhou JL, Chen YN, et al. Near-infrared light-boosted photodynamic-immunotherapy based on sulfonated metal-organic framework nanospindle. Chem Eng J. 2022;437:135370. doi: 10.1016/j.cej.2022.135370
   Web of Science ®Google Scholar
• Zhang M, Dai Z, Theivendran S, et al. Nanotechnology enabled reactive species regulation in biosystems for boosting cancer immunotherapy. Nano Today. 2021;36(1):101035. doi: 10.1016/j.nantod.2020.101035
   Google Scholar
• Hou X, Tao Y, Pang Y, et al. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment. Int J Cancer. 2018;143(12):3050–3060. doi: 10.1002/ijc.31717
   PubMed Web of Science ®Google Scholar
• Zhu XL, Zhang YJ, Huang HQ, et al. Folic acid-modified and functionalized CuS nanocrystal-based nanoparticles for combined tumor chemo- and photothermal therapy. J Drug Target. 2017;25(5):425–435. doi: 10.1080/1061186X.2016.1266651
   PubMed Web of Science ®Google Scholar
• Zhu HY, Liu WW, Cheng ZT, et al. Targeted delivery of siRNA with pH-responsive hybrid gold nanostars for cancer treatment. Int J Mol Sci. 2017;18(10):2029. doi: 10.3390/ijms18102029
   PubMed Web of Science ®Google Scholar
• Zhu HJ, Cheng PH, Chen P, et al. Recent progress in the development of near-infrared organic photothermal and photodynamic nanotherapeutics. Biomater Sci. 2018;6(4):746–765. doi: 10.1039/C7BM01210A
   PubMed Web of Science ®Google Scholar
• Al-Jadir TM, and Siperstein FR. Modeling and simulation of adsorption of methane, ethane, hydrogen sulfide and water from natural gas in (fp)yeu metal–organic framework. IOP Conf Ser Mater Sci Eng. 2019;579(1):012020–212. doi: 10.1088/1757-899X/579/1/012020
   Google Scholar
• Xu ZJ, Wu ZY, Huang S, et al. A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment. Journal Of Controlled Release. 2023;354:615–625. doi: 10.1016/j.jconrel.2023.01.024
   PubMed Web of Science ®Google Scholar
• Rodríguez-Ramos R, Santana-Mayor L, Socas Rodríguez B, et al., Applications of metal-organic frameworks in analytical chemistry. In Metal-organic frameworks for chemical reactions. Chapter 9p. 167–230; 2021. doi: 10.1016/B978-0-12-822099-3.00009-5
   Google Scholar
• Tu TN, Nguyen MV, Nguyen HL, et al. Designing bipyridine-functionalized zirconium metal–organic frameworks as a platform for clean energy and other emerging applications. Coordination Chemistry Reviews. 2018;364(6):33–50. doi: 10.1016/j.ccr.2018.03.014
   Google Scholar
• Cheng Q, Li ZH, Sun YX, et al. Controlled synthesis of a core-shell nanohybrid for effective multimodal image-guided combined photothermal/photodynamic therapy of tumors. Npg Asia Mater. 2019;11(1):63. doi: 10.1038/s41427-019-0164-4
   Google Scholar
• Wei GH, Lian X, Qin XD, et al. Core-satellite porphyrinic MOF@CuS nanoconstructs for combined chemodynamic/photodynamic/photothermal therapy. Mater Design. 2022;224:111302. doi: 10.1016/j.matdes.2022.111302
   Web of Science ®Google Scholar
• Huang J, Liu F, Han X, et al. Nanosonosensitizers for highly efficient sonodynamic cancer theranostics. Theranostics. 2018;8(22):6178–6194. doi: 10.7150/thno.29569
   PubMed Web of Science ®Google Scholar
• Pan X, Bai L, Wang H, et al. Metal- organic-framework-derived carbon nanostructure augmented sonodynamic cancer therapy. Adv Mater. 2018;30(23):1800180. doi: 10.1002/adma.201800180
   Web of Science ®Google Scholar
• Deng XY, Shao ZW, Zhao YL. Solutions to the drawbacks of photothermal and photodynamic cancer therapy. Adv Sci. 2021;8(3):2002504. doi: 10.1002/advs.202002504
   Web of Science ®Google Scholar
• He QJ, Chen DY, Fan MJ. Progress of precision nanomedicine-mediated gas therapy. J Inorg Mater. 2018;33(8):811–824. doi: 10.15541/jim20170529
   Web of Science ®Google Scholar
• Andreadou I, Iliodromitis EK, Rassaf T, et al. A. papapetropoulos, P. Ferdinandy, the role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Brit J Pharmacol. 2015;172(6):1587–1606. doi: 10.1111/bph.12811
   PubMed Web of Science ®Google Scholar
• Módis K, Bos EM, Calzia E, et al. Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects. Brit J Pharmacol. 2014;171(8):2123–2146. doi: 10.1111/bph.12368
   PubMed Web of Science ®Google Scholar
• Wegiel B, Gallo D, Csizmadia E, et al. Carbon monoxide expedites metabolic ex-haustion to inhibit tumor growth. Canc Res. 2013;73(23):7009–7021. doi: 10.1158/0008-5472.CAN-13-1075
   PubMed Web of Science ®Google Scholar
• Jin Z, Wen Y, Xiong L, et al. Intratumoral H2O2-triggered release of co from metal carbonyl-based nanomedicine for efficient co therapy. Chem Comm. 2017;53(40):5557–5560. doi: 10.1039/C7CC01576C
   PubMed Web of Science ®Google Scholar
• Carpenter AW, Schoenfisch MH. Nitric oxide release Part II. Ther App Cheminform. 2012;43(31):201231269. doi: 10.1002/chin.201231269
   Google Scholar
• Zhou HF, Yan HM, Hu Y, et al. Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide. ACS Nano. 2014;8(7):7305–7317. doi: 10.1021/nn502372n
   PubMed Web of Science ®Google Scholar
• Fan WP, Yung BC, Chen XY. Stimuli-responsive NO release for on-demand gas-sensitized combined cancer therapy, Angew. Chem Int Ed. 2018;57(28):8383–8394. doi: 10.1002/anie.201800594
   PubMed Web of Science ®Google Scholar
• Huang XH, Xu F, Hou H, et al. Stimuli-responsive nitric oxide generator for light-triggered synergistic cancer photothermal/gas therapy. Nano Res. 2019;12(6):1361–1370. doi: 10.1007/s12274-019-2307-x
   Web of Science ®Google Scholar
• Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev. 2007;6(8):662–680. doi: 10.1038/nrd2222
   Google Scholar
• Wan SS, Zeng JY, Cheng H, et al. ROS-induced NO generation for gas therapy and sensitizing photodynamic therapy of tumor. Biomaterials. 2018;185:51–62. doi: 10.1016/j.biomaterials.2018.09.004
   PubMed Web of Science ®Google Scholar
• Zhang K, Xu HX, Jia XQ, et al. Ultrasound-triggered nitric oxide release platform based on energy Transformation for targeted Inhibition of Pancreatic tumor. ACS Nano. 2016;10(12):10816–10828. doi: 10.1021/acsnano.6b04921
   PubMed Web of Science ®Google Scholar
• Hu J, Wu WR, Qin YF, et al. Fabrication of Glyco‐metal‐organic frameworks for targeted interventional photodynamic/chemotherapy for hepatocellular carcinoma through percutaneous transperitoneal puncture. Adv Funct Mater. 2020;30(19):1910084. doi: 10.1002/adfm.201910084
   Web of Science ®Google Scholar
• Li SY, Zhao LP, Zheng RR, et al. Tumor microenvironment adaptable nanoplatform for O2 Self-Sufficient chemo/photodynamic combination therapy. Part Part Syst Charact. 2020;37(3):1900496. doi: 10.1002/ppsc.201900496
   Web of Science ®Google Scholar
• Feng L, Chen MY, Li RH, et al. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/photodynamic therapy. Acta Biomaterialia. 2022;138:463–477. doi: 10.1016/j.actbio.2021.10.032
   PubMed Web of Science ®Google Scholar
• Hu XC, Li RH, Wu WJ, et al. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy. J Control Release. 2022;348:660–671. doi: 10.1016/j.jconrel.2022.06.019
   PubMed Web of Science ®Google Scholar
• Mahapatra AK, Murthy PN, Chandana S, et al. Progress with liposomal drug delivery systems: formulation to therapy. Der Pharmacia Lettre. 2017;6(3):110–128.
   Google Scholar
• Sianipar NF, Assidqi K, Yuliani S, et al. Anticancer activity of nanoemulsion formulation of rodent tuber mutant extract (typhonium flagelliforme) on human breast cancer cell line. Rasayan J Chem. 2021;14(1):535–544. doi: 10.31788/RJC.2021.1415742
   Google Scholar
• Wang CP, Wang XY, Dong KY, et al. Injectable and responsively degradable hydrogel for personalized photothermal therapy. Biomaterials. 2016;104:129–137. doi: 10.1016/j.biomaterials.2016.07.013
   PubMed Web of Science ®Google Scholar
• Yu H, Yang P, Jia Y, et al. Regulation of biphasic drug release behavior by graphene oxide in polyvinyl pyrrolidone/poly(ε-caprolactone) core/sheath nanofiber mats. Colloids Surfaces B. 2016;146(1):63–69. doi: 10.1016/j.colsurfb.2016.05.052
   PubMedGoogle Scholar
• Cherkasov VR, Mochalova EN, Babenyshev AV, et al. Antibody-directed metal-organic framework nanoparticles for targeted drug delivery. Acta Biomaterialia. 2020;103:223–236. doi: 10.1016/j.actbio.2019.12.012
   PubMed Web of Science ®Google Scholar
• Liu J, Yang Z, Che Y, et al. Computational investigation of metal organic frameworks as potential drug carriers for antihypertensive amlodipine. AIChE J. 2021;68(1):17474-1 -17474–13. doi: 10.1002/aic.17474
   Web of Science ®Google Scholar
• Sarker M, Shin S, Jhung SH. Functionalized mesoporous metal-organic framework PCN-100: an efficient carrier for vitamin E storage and delivery. J Ind Eng Chem. 2019;74:158–163. doi: 10.1016/j.jiec.2019.02.022
   Web of Science ®Google Scholar
• Nguyen MH, Tran TT, Hadinoto K. Controlling the burst release of amorphous drug–polysaccharide nanoparticle complex via crosslinking of the polysaccharide chains. Eur J Pharm Biopharm. 2016;104:156–163. doi: 10.1016/j.ejpb.2016.05.006
   PubMed Web of Science ®Google Scholar
• Tran T-T, Nguyen MH, Tan YZ, et al. Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications. Eur J Pharm Biopharm. 2017;112:196–203. doi: 10.1016/j.ejpb.2016.11.030
   PubMed Web of Science ®Google Scholar
• Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73(2):121–136. doi: 10.1016/S0168-3659(01)00248-6
   PubMed Web of Science ®Google Scholar
• da Silva EP, Guilherme MR, Garcia FP, et al. Drug release profile and reduction in the in vitro burst release from pectin/HEMA hydrogel nanocomposites crosslinked with titania. RSC Adv. 2016;6(23):19060–19068. doi: 10.1039/C5RA27865A
   Web of Science ®Google Scholar
• Zhao XW, Zou X, Ye L. Controlled pH- and glucose-responsive drug release behavior of cationic chitosan based nano-composite hydrogels by using graphene oxide as drug nanocarrier. J Ind Eng Chem. 2016;49:36–45. doi: 10.1016/j.jiec.2016.12.023
   Web of Science ®Google Scholar
• Chuna NY, Kimb SN, Choia YS, et al. PCN-223 as a drug carrier for potential treatment of colorectal cancer. J Ind Eng Chem. 2020;84:290–296. doi: 10.1016/j.jiec.2020.01.010
   Web of Science ®Google Scholar